Oliver Wisco, DO
MOHS-Micrographic Surgery · Bend, ORNPI 1164545166
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,916 of the $12,712 with a category attached, or 70.1%. 25 manufacturers reported payments, led by Sanofi at 46.4% of the total.
Across 130 payments — averaging $97.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$6K
- Regeneron Healthcare Solutions, Inc.$4K
- E.r. Squibb & Sons, L.L.C.$849
- Lilly USA, LLC$671
- Sun Pharmaceutical Industries Inc.$246
- AbbVie$234
- plus $1K from 19 others
Across 12 payments — averaging $1908.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$23K
What the payments were for
- Consulting fees$8,91670%
- Food & beverage$3,68129%
- Education$1161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 15 | $5,901 |
| Regeneron Healthcare Solutions, Inc. | 11 | $3,650 |
| E.r. Squibb & Sons, L.L.C. | 25 | $849 |
| Lilly USA, LLC | 19 | $671 |
| Sun Pharmaceutical Industries Inc. | 8 | $246 |
| AbbVie | 8 | $234 |
| Johnson & Johnson | 4 | $198 |
| Surgenex LLC | 5 | $136 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $129 |
| Blueprint Medicines Corporation | 1 | $77 |
| Boehringer Ingelheim | 1 | $76 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| Amgen | 4 | $75 |
| Merz North America, Inc. | 2 | $64 |
| Genentech USA, Inc. | 3 | $47 |
| Incyte Corporation | 3 | $45 |
| DUSA Pharmaceuticals, Inc. | 2 | $39 |
| UCB, Inc. | 2 | $39 |
| Mimedx Group, Inc. | 2 | $36 |
| LEO Pharma Inc. | 1 | $28 |
| Smith+Nephew | 1 | $28 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Kerecis Limited | 1 | $18 |
| Biofrontera Inc. | 3 | $17 |
| Dermavant Sciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few mohs-micrographic surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $70,818 |
| Fluorouracil | 86 | $6,258 |
| Clobetasol Propionate | 65 | $6,031 |
| Calcipotriene | 16 | $2,053 |
| Metronidazole | 42 | $1,824 |
| Imiquimod | 26 | $1,265 |
| Doxycycline Monohydrate | 96 | $1,221 |
| Tretinoin | 12 | $1,006 |
| Ketoconazole | 56 | $966 |
| Acitretin | 12 | $656 |
| Triamcinolone Acetonide | 47 | $299 |
| Doxycycline Hyclate | 31 | $253 |
| ValacyclovirValacyclovir Hcl | 15 | $246 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Bend
- Gerald PetersBend$3K
- Anna BarPortland$63K
- Wesley YuPortland$15K
- Jarett CasaleSalem$6K
- Lindsey FixSpringfield$5K
- Jennifer BarklundMedford$2K
- Tamar HajarPortland$2K
- Nolan MaloneyMedford$2K
- William LearSalem$1K
- Sarah FitzmauricePortland$963
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.